Skip to content
2000
Volume 3, Issue 2
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

Changes in lipids and lopinavir plasma concentrations were examined in 40 HIV-patients exposed to lopinavir/ ritonavir 400/100 mg BID, formulated as tablets and as capsules. Triglycerides and total/HDL-cholesterol ratio were significantly lower with tablets than with capsules. Lopinavir concentrations were higher with tablets than with capsules.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231209788654036
2009-04-01
2025-09-11
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231209788654036
Loading

  • Article Type:
    Research Article
Keyword(s): cardiovascular risk; dislipidemia; HIV; Lopinavir; metabolic complications; pharmacokinetics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test